Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • volasertib

    - PMLiVE

    Roche and Oxford BioTherapeutics enter oncology partnership worth over $1bn

    The companies will aim to discover new antibody-based therapeutics for cancer

    - PMLiVE

    FDA approves Shorla Oncology’s Imkeldi to treat leukaemia and other cancers

    The solution is an advanced liquid formulation of the tyrosine kinase inhibitor imatinib mesylate

    - PMLiVE

    Innovative Trials Announces New Charity Partnerships

    Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year

    Innovative Trials

    - PMLiVE

    Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership

    The strategic agreement also gives Lilly the exclusive right to acquire the biotech for $1bn

    tijana being interviewed

    Envision Analogue – An Introduction

    Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...

    Genesis Research Group

    - PMLiVE

    Ipsen enters $900m licensing agreement for Sutro Biopharma’s ADC candidate

    STRO-003 will be the first ADC candidate to be added to Ipsen’s portfolio

    - PMLiVE

    New technique enables study of immune response to cancer using archived tissue samples

    FUME-TCRseq was shown to successfully read formalin-fixed paraffin-embedded tissue samples

    - PMLiVE

    Gilead and Merus announce oncology partnership worth over $1.5bn

    The companies will aim to discover dual tumour-associated antigens targeting trispecific antibodies

    - PMLiVE

    Researchers develop screening tool to investigate mechanisms behind multiple diseases

    The technique will assess genetic changes in cells behind cancer, autoimmunity and neurodegeneration

    - PMLiVE

    ‘Click chemistry’ system used to map new class of drug targets in cancer and immunology

    The novel tagging system won the Nobel Prize in Chemistry in October 2022

    - PMLiVE

    Gilead gains rights to Compugen’s immunotherapy programme in deal worth $848m

    The high affinity antibody blocks the interaction between IL-18 binding protein and IL-18

    - PMLiVE

    Merck and Owkin collaborate to develop AI-powered diagnostics for cancer

    The companies aim to develop a pre-screening test to improve MSI-H testing for cancer

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links